Global Migraine Market 2016 Edition Report: Share, Size, Trends, Market Dynamics & Competitive Landscape Analysis Discussed in New Research Report
PUNE, India, May 17, 2016 /PRNewswire-iReach/ -- Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to result from the activation and sensitization of sensory neurons that have nerve endings in meningeal blood vessels. Migraines can be episodic or chronic. Chronic Migraine (CM) and Episodic Migraine (EM) are both part of the spectrum of migraine disorders, but are distinct clinical entities. The onset of migraine is preceded by certain triggers, which can be unique for each migraine sufferer.
Photo - http://photos.prnewswire.com/prnh/20160517/368523LOGO
The Global Migraine Market Report: 2016 Edition research of 45 pages with 35 Charts and 5 Tables, 4 company profiles to the pharmaceuticals industry segment of its online data and intelligence library, now available at http://www.marketreportsonline.com/477194.html.
Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to result from the activation and sensitization of sensory neurons that have nerve endings in meningeal blood vessels. Migraines can be episodic or chronic. Chronic Migraine (CM) and Episodic Migraine (EM) are both part of the spectrum of migraine disorders, but are distinct clinical entities. The onset of migraine is preceded by certain triggers, which can be unique for each migraine sufferer.
The migraine market is expected to acquire modest growth driven by launch of new therapies and increasing rate of drug treatment due to increasing female population and rising awareness among physicians and patients. The major growth drivers of the migraine market includes rising spending on medicines, growing female population, increasing cigarette consumption and healthcare expenditure. However, the growth of the market will also remain challenged by complications associated with Triptans, treatment limitations for patients with CV (Cardio Vascular) risk and increased preference for OTC (Over the Counter) medications.
Triptans and Ergots are among the most common drug options existing in the treatment market for migraine. The global migraine treatment market currently faces several unmet needs and is saturated with the availability of generic drugs. Several branded drugs are under development with safer and more effective profiles, given the vast opportunities existing in the market. The focus of upcoming drugs is to either cure migraine or to reduce the frequency to a level where patients can find tolerable relief.
Purchase a copy of this migraine market research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=477194.
The report, "Global Migraine Market" analyzes the currently prevailing condition of the market along with its future scope of development. The specific market of the U.S. is being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.
Major Points from Table of Contents (http://www.marketreportsonline.com/477194-toc.html) provided in Global Migraine Market Report: 2016 Edition:
1. Market Overview1.1 Introduction1.2 Types1.3 Causes and Pathogenesis1.4 Symptoms and Diagnosis1.5 Treatment Options
2. Global Migraine Market2.1 Global Migraine Drug Market by Value2.2 Global Migraine Drug Market by Category2.3 Global Therapeutic Botulinum Toxin Market by Value2.4 Global Therapeutic Botulinum Toxin Market by Indication
3. The U.S. Migraine Market3.1 The U.S. Total Migraine Population3.2 The U.S. Migraine Population by Diagnosis3.3 The U.S. Migraine Population with CV Risk Factors3.4 The U.S Preventive Migraine Treatment by Specialty3.5 The U.S. Acute Migraine Treated Population by Drug Type3.6 The U.S. Acute Migraine Prescription Volume3.7 The U.S. Migraine Drugs Revenue3.7.1 Cambia3.7.2 Lasmiditan
4. Market Dynamics
4.1 Growth Drivers4.1.1 Rising Spending on Medicines4.1.2 Growing Female Population4.1.3 Increasing Cigarette Consumption4.1.4 Rising Healthcare Expenditure
4.2 Trends4.2.1 Emergence of Peripheral Nerve Stimulators4.2.2 Increased Preference for Non Pharmacological Treatment4.2.3 Higher Prevalence of Migraine than Other Chronic Diseases4.2.4 Recurrent Symptoms in Migraine Patients4.2.5 Drugs under Development for Migraine
4.3 Challenges4.3.1 Complications associated with Triptans4.3.2 Treatment Limitations for Patients with Cardiovascular Disease4.3.3 Rise in Prescription Drugs to OTC Switch
5. Competitive Landscape
6. Company Profiles
Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.
About Us:MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Media Contact: Ritesh Tiwari, Market Reports Online, + 1 888 391 5441, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Market Reports Online